Table 5.
Parameter | HR (95% CI) | p Value |
---|---|---|
Gender | ||
Male | Ref | |
Female | 1.074 (0.618–1.868) | 0.800 |
Neoadjuvant Chemotherapy | ||
Yes | Ref | |
No | 1.307 (0.567–3.011) | 0.530 |
Resection | ||
Conventional | Ref | |
Complex | 1.219 (0.643–2.309) | 0.544 |
Exploration | 1.873 (0.775–4.525) | 0.163 |
Resection Margin | ||
R0 | Ref | |
No R0 | 2.964 (1.638–5.363) | <0.001 |
UICC | ||
Stage I | Ref | |
Stage II | 4.160 (1.171–14.780) | 0.028 |
Stage III | 4.335 (1.107–16.986) | 0.035 |
Stage IV | 5.329 (1.604–17.705) | 0.006 |